In this review:
- SURMOUNT-4: continued tirzepatide for weight loss maintenance
- SURPASS: tirzepatide in type 2 diabetes
- Precision medicine for GDM prevention
- Major oral anti-hyperglycaemic therapies in type 3c diabetes
- Management considerations for type 3c diabetes
- Kidney outcomes with semaglutide in type 2 diabetes & chronic kidney disease
- CV outcomes with SGLT-2is + GLP-1RAs in type 2 diabetes
- Empagliflozin + semaglutide in albuminuric type 2 diabetes
- Infection risk in hyperinsulinaemic type 2 diabetes
- Long-term mortality & recurrent diabetic ketoacidosis admissions
- COMISAIR: continuous glucose monitoring in type 1 diabetes
Please login below to download this issue (PDF)